Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual atropine for clozapine-induced hypersalivation
ACTRN12618000051246Phase 2Completed
- Sponsor
- The University of Sydney
- Start
- Sep 2017
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of atropine in clozapine-induced hypersalivation (CIS) (2 arms), sponsored by The University of Sydney. Primary endpoint: Mean change in saliva flow rate. Started Sep 2017; status: completed.
02
Drugs
atropine
03
Conditions
clozapine-induced hypersalivation (CIS)
Beyond the preview
Go deeper on ACTRN12618000051246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000051246.